Establishment Labs Holdings (3E0) Price & Analysis

1 Followers

3E0 Stock Chart & Stats

€79.92

-€1.26(-1.55%)

At close: Jul 24 4:00 PM EDT

€79.92

-€1.26(-1.55%)

Day’s Range― - ―

52-Week Range€30.60 - €83.28

Previous CloseN/A

Volume0.00

Average Volume (3M)9.00

Market Cap

€1.84B

Enterprise Value€2.78K

Total Cash (Recent Filing)€71.16M

Total Debt (Recent Filing)€263.67M

Price to Earnings (P/E)―

Beta0.76

Next Earnings

Nov 10, 2026

EPS Estimate

-0.22

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.31

Shares Outstanding29,801,891

10 Day Avg. Volume0

30 Day Avg. Volume9

Financial Highlights & Ratios

PEG Ratio0.99

Price to Book (P/B)91.68

Price to Sales (P/S)10.23

P/FCF Ratio-37.47

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€87.86

Price Target Upside9.93% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering7

EPS Forecast (FY)-1.03

Revenue Forecast (FY)€231.08M

Bulls Say, Bears Say

Bulls Say

Revenue Growth And U.S. ExpansionRapid revenue growth and strong U.S. adoption are expanding the company’s served market. U.S. revenue rose 216% year over year and is expected to exceed 30% of 2026 revenue, creating a larger platform for future scale.

Margin And EBITDA ImprovementThe combination of premium gross margins and improving EBITDA indicates operating leverage as revenue scales. Management’s expectation of positive adjusted EBITDA each quarter in 2026 supports a credible path toward sustainable profitability.

Product Differentiation And AdoptionStrong clinical outcomes and surgeon adoption can reinforce Motiva’s differentiation with providers and patients. The minimally invasive platform also broadens the product offering and may support durable demand, premium positioning, and market-share gains.

Bears Say

Persistent Negative Cash FlowThe company remains dependent on external funding or balance-sheet flexibility while operating cash flow is negative. Although cash burn has improved, sustained investment needs and delayed cash conversion could constrain growth or require additional financing.

Debt And PIK Interest ExposureThe enlarged facility provides liquidity for expansion but increases financial risk if growth or cash conversion disappoints. PIK interest preserves near-term cash while adding to future obligations, potentially reducing flexibility before profitability is established.

High Operating Expense BaseHeavy commercial and operating investment is necessary for the U.S. launch but leaves limited margin for execution errors. If adoption, collections, or revenue growth slow, the elevated expense base could delay breakeven and prolong losses.

Establishment Labs Holdings News

Establishment Labs upgraded to Buy from Neutral at Citi

Citi upgraded Establishment Labs (ESTA) to Buy from Neutral with a $92 price target Published first on TheFly...

11d ago

ESTA

Citi upgrades Establishment Labs to Buy on recent pullback

Citi upgraded Establishment Labs (ESTA) to Buy from Neutral with an unchanged price target of $92. The shares...

11d ago

ESTA

Five Below upgraded, StubHub downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

11d ago

ALC

Establishment Labs price target raised to $105 from $90 at Canaccord

Canaccord analyst Caitlin Roberts raised the firm’s price target on Establishment Labs (ESTA) to $105 from $90 and...

21d ago

ESTA

Establishment Labs price target raised to $103 from $96 at BTIG

BTIG raised the firm’s price target on Establishment Labs (ESTA) to $103 from $96 and keeps a Buy...

21d ago

ESTA

Establishment Labs reports Q2 EPS (39c), consensus (34c)

Reports Q2 revenue $67.5M, consensus $65.78M. “Momentum continued throughout the second quarter and into the third quarter as...

22d ago

ESTA

Establishment raises FY26 revenue view to $269M-$271M from $266.5M-$268.5M

Consensus $267.48M Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>...

22d ago

ESTA

Establishment Labs price target raised to $117 from $95 at TD Cowen

TD Cowen raised the firm’s price target on Establishment Labs (ESTA) to $117 from $95 and keeps a...

25d ago

ESTA

Buy Rating Reaffirmed as Margin Outlook Improves and Silicone Supply Secured; $117 Price Target Maintained

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Establishment Labs Holdings,...

14d ago

ESTA

Josh Jennings Raises Establishment Labs Price Target to $117 on Strengthening U.S. Performance and Expanding Motiva & Preservé Adoption

Establishment Labs Holdings, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Josh Jennings...

25d ago

ESTA

Establishment Labs price target raised to $105 from $100 at Mizuho

Mizuho analyst Anthony Petrone raised the firm’s price target on Establishment Labs (ESTA) to $105 from $100 and...

1M ago

ESTA

Establishment Labs price target raised to $96 from $90 at BTIG

BTIG analyst Sam Eiber raised the firm’s price target on Establishment Labs (ESTA) to $96 from $90 and...

2M ago

ESTA

Establishment Labs Appoints Veteran Executive Taylor Harris to Board

Establishment Labs Holdings ( ($ESTA) ) has shared an update. On June 24, 2026, Establishment Labs appointed veteran...

2M ago

ESTA

Establishment Labs Shareholders Reaffirm Board, Pay and Auditor

Establishment Labs Holdings ( ($ESTA) ) has issued an update. On May 22, 2026, Establishment Labs Holdings held...

3M ago

ESTA

3E0 FAQ

What was Establishment Labs Holdings Inc’s price range in the past 12 months?

Establishment Labs Holdings Inc lowest stock price was €30.60 and its highest was €83.28 in the past 12 months.

What is Establishment Labs Holdings Inc’s market cap?

Establishment Labs Holdings Inc’s market cap is €1.84B.

When is Establishment Labs Holdings Inc’s upcoming earnings report date?

Establishment Labs Holdings Inc’s upcoming earnings report date is Nov 10, 2026 which is in 74 days.

How were Establishment Labs Holdings Inc’s earnings last quarter?

Establishment Labs Holdings Inc released its earnings results on Aug 06, 2026. The company reported -€0.334 earnings per share for the quarter, missing the consensus estimate of -€0.288 by -€0.045.

Is Establishment Labs Holdings Inc overvalued?

According to Wall Street analysts Establishment Labs Holdings Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Establishment Labs Holdings Inc pay dividends?

Establishment Labs Holdings Inc does not currently pay dividends.

What is Establishment Labs Holdings Inc’s EPS estimate?

Establishment Labs Holdings Inc’s EPS estimate is -0.22.

How many shares outstanding does Establishment Labs Holdings Inc have?

Establishment Labs Holdings Inc has 29,801,891 shares outstanding.

What happened to Establishment Labs Holdings Inc’s price movement after its last earnings report?

Establishment Labs Holdings Inc reported an EPS of -€0.334 in its last earnings report, missing expectations of -€0.288. Following the earnings report the stock price went down -2.896%.

Which hedge fund is a major shareholder of Establishment Labs Holdings Inc?

Currently, no hedge funds are holding shares in DE:3E0

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Establishment Labs Holdings Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

6.75%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Establishment Labs Holdings Inc

Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.

Establishment Labs Holdings (3E0) Earnings & Revenues

Historic Earnings Reports

3E0 Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call communicated strong operational and commercial momentum led by a rapid U.S. launch, 45% YoY revenue growth in Q1, improving gross margin (70.7%) and a return to positive adjusted EBITDA. Key product innovations (minimally invasive platform) are driving adoption, surgeon and patient demand, and management raised full-year revenue guidance. Offsetting factors include elevated operating expenses, near-term cash usage and increased debt with PIK mechanics, plus some supply and geopolitical uncertainties. Overall, the positives around revenue acceleration, margin expansion, product differentiation and pathway to cash-flow positivity materially outweigh the risks discussed.View all DE:3E0 earnings summaries

3E0 Stock 12 Month Forecast

Average Price Target

€87.86

▲(9.93% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"33":"€33","102":"€102","50.25":"€50.3","67.5":"€67.5","84.75":"€84.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":101.06114148,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€101.06</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":87.85779332571428,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€87.86</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":79.46688048,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€79.47</span>\n  </div></div>","useHTML":true}}],"tickPositions":[33,50.25,67.5,84.75,102],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.42,82.93085703692307,84.44171407384616,85.95257111076923,87.46342814769231,88.97428518461538,90.48514222153847,91.99599925846154,93.50685629538462,95.0177133323077,96.52857036923078,98.03942740615385,99.55028444307692,{"y":101.06114148,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.42,81.91521487120879,82.41042974241758,82.90564461362638,83.40085948483517,83.89607435604395,84.39128922725274,84.88650409846154,85.38171896967033,85.87693384087912,86.3721487120879,86.86736358329671,87.3625784545055,{"y":87.85779332571428,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.42,81.26976003692307,81.11952007384616,80.96928011076923,80.8190401476923,80.66880018461539,80.51856022153846,80.36832025846154,80.21808029538461,80.0678403323077,79.91760036923077,79.76736040615384,79.61712044307693,{"y":79.46688048,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":35,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.6,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.44,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.82,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.42,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >